Unknown

Dataset Information

0

Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.


ABSTRACT:

Main objective

To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in non-users.

Methods

This was a retrospective cohort study of new amphetamines (n=38,586) or atomoxetine (n=20,995) users. Each medication user was matched to up to four non-users on age, gender, data source, and state (n=238,183). The following events were primary outcomes of interest 1) sudden death or ventricular arrhythmia, 2) stroke, 3) myocardial infarction, 4) a composite endpoint of stroke or myocardial infarction. Cox proportional hazard regression was used to calculate propensity-adjusted hazard ratios for amphetamines versus matched non-users and atomoxetine versus matched non-users, with intracluster dependence within matched sets accounted for using a robust sandwich estimator.

Results

The propensity-score adjusted hazard ratio for amphetamines use versus non-use was 1.18 (95% CI: 0.55-2.54) for sudden death/ventricular arrhythmia, 0.80 (95% CI: 0.44-1.47) for stroke, 0.75 (95% CI: 0.42-1.35) for myocardial infarction, and 0.78 (95% CI: 0.51-1.19) for stroke/myocardial infarction. The propensity-score adjusted hazard ratio for atomoxetine use versus non-use was 0.41 (95% CI: 0.10-1.75) for sudden death/ventricular arrhythmia, 1.30 (95% CI: 0.52-3.29) for stroke, 0.56 (95% CI: 0.16-2.00) for myocardial infarction, and 0.92 (95% CI: 0.44-1.92) for stroke/myocardial infarction.

Conclusions

Initiation of amphetamines or atomoxetine was not associated with an elevated risk of serious cardiovascular events. However, some of the confidence intervals do not exclude modest elevated risks, e.g. for sudden death/ventricular arrhythmia.

SUBMITTER: Schelleman H 

PROVIDER: S-EPMC3559703 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.

Schelleman Hedi H   Bilker Warren B WB   Kimmel Stephen E SE   Daniel Gregory W GW   Newcomb Craig C   Guevara James P JP   Cziraky Mark J MJ   Strom Brian L BL   Hennessy Sean S  

PloS one 20130130 1


<h4>Main objective</h4>To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in non-users.<h4>Methods</h4>This was a retrospective cohort study of new amphetamines (n=38,586) or atomoxetine (n=20,995) users. Each medication user was matched to up to four non-users on age, gender, data source, and state (n=238,183). The following events were primary outcomes of interest 1) sudden death or ventricular arrhythmia, 2) stroke, 3) m  ...[more]

Similar Datasets

| S-EPMC6982643 | biostudies-literature
| S-EPMC3350308 | biostudies-literature
| S-EPMC4943074 | biostudies-literature
| S-EPMC3168618 | biostudies-literature
| S-EPMC3493624 | biostudies-literature
| S-EPMC3344735 | biostudies-other
| S-EPMC6339526 | biostudies-literature
| S-EPMC3532497 | biostudies-literature
| S-EPMC6513464 | biostudies-literature
| S-EPMC4390156 | biostudies-literature